Siren »

Omega Therapeutics shares owned by Siren

Quarter-by-quarter ownership of Omega Therapeutics (OMGA) shares owned by Siren from 13F filings

Historical chart of Siren investment in Omega Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Omega Therapeutics held by Siren consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Omega Therapeutics by Siren

Quarter filed Position value Share count Share price at filing
2024-09-30 $1.6M 1.3M 1.22

More positions owned by Siren

Kymera Therapeutics (KYMR)
Beigene Sponsored Adr (BGNE)
Scholar Rock Hldg Corp (SRRK)
Bicara Therapeutics
Argenx SE Sponsored Adr (ARGX)
Crinetics Pharmaceuticals In (CRNX)
Avidity Biosciences Ord (RNA)
Apellis Pharmaceuticals (APLS)
Lexicon Pharmaceuticals Com New (LXRX)
Igm Biosciences (IGMS)
Centessa Pharmaceuticals Sponsored Ads (CNTA)
Ascendis Pharma A/S Sponsored Adr (ASND)
Silence Therapeutics Ads (SLN)
Arrowhead Pharmaceuticals (ARWR)
WAVE Life Sciences SHS (WVE)

View all positions for Siren

Top funds holding Omega Therapeutics

Flagship Ventures Management
Siren
Vanguard Group
Blue Owl Capital Holdings
683 Capital Management
Renaissance Technologies
BlackRock
72 Investment Holdings
Platinum Investment Mangement
State Treasurer State Of Michigan
BlackRock
Geode Capital Management
Squarepoint Ops
Goldman Sachs Group
Bridgeway Capital Management

View all funds holding Omega Therapeutics